ImageneBio, Inc.
IMA
$5.82
-$0.20-3.32%
NASDAQ
Corporate Info
Website
Phone Number
858 345 6265
Address
12526 High Bluff Drive
Suite 345
San Diego, CA 92130
Suite 345
San Diego, CA 92130
Country
United States
Year Founded
--
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
9
Business Description
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.